Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000062391-97-000017
Filing Date
1997-08-07
Accepted
1997-08-07 00:00:00
Documents
1
Group Members
HMR PHARMA, INC.HOECHST MARION ROUSSEL INC
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 HMRI/HMR PHARMA AMEND 6 TO ONCOGENE 13D SC 13D/A 14050
  Complete submission text file 0000062391-97-000017.txt   16408
Mailing Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627
Business Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627 8169665000
HOECHST MARION ROUSSEL INC (Filed by) CIK: 0000062391 (see all company filings)

EIN.: 440565557 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-37954 | Film No.: 97653056
SIC: 2835 In Vitro & In Vivo Diagnostic Substances